Featured

24 January 2024

ACCORD: new guideline to support consistent and complete reporting of consensus methods in biomedical research

Oxford PharmaGenesis has contributed to the development of the new ACCORD reporting guideline to help the medical and scientific communities to improve the reporting of research involving consensus methodologies. The guideline was published in the non-profit open access journal PLOS Medicine.

All
  • All
  • News
  • Articles
  • Events

Bridging the gap in communications at the Patient Summit Europe 2019

Oxford PharmaGenesis was delighted to attend the recent eyeforpharma Patient Summit Europe in London.

Continue reading
ISMPP-APAC2

ISMPP Asia-Pacific joins the push for open science in pharma

Oxford PharmaGenesis was in Tokyo to see ‘open science’ take centre stage at the 2019 Asia-Pacific Meeting of ISMPP

Continue reading
OxPh140-300x200@2x

Oxford consultancy receives second royal honour for international trade

Lord Lieutenant leads celebrations at global Oxford-based consultancy

Continue reading
professional-medical-writing

Professional medical writers improve the quality and speed of clinical trial reporting

A systematic review of the impact of professional medical writing support on the quality, ethics and timeliness of clinical trial reporting has been published in Research Integrity and Peer Review.

Continue reading
TIPPA2019_GeorgeWashington

Oxford PharmaGenesis attends TIPPA East 2019

Both the Oxford PharmaGenesis US (Brian Falcone and Jake Willet) and UK (Eric Southam and Richard White) offices were represented at The International Publication Planning Meeting (TIPPA) East, in Boston on 24–25 June 2019.

Continue reading
content32T3XBOQ-1-300x225@2x

Aspiring to new heights: Oxford PharmaGenesis completes the Three Peaks Challenge for charity

In aid of three Oxfordshire-based charities, three employees of HealthScience communications consultancy Oxford PharmaGenesis scaled the three highest peaks in England, Scotland and Wales within 24 hours comprising the Trifecta 3Peaks Challenge.

Continue reading